Human aging and melatonin. Clinical relevance

Experimental Gerontology

Volumn 36, Issue 7, 2001, Pages 1083-1100

  Touitou, Yvan ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Aging; Blindness; Circadian rhythm; Desynchronization; Melatonin; Pharmacokinetics; Sleep

Indexed keywords

FREE RADICAL; MELATONIN;

AGED; AGING; BLINDNESS; CIRCADIAN RHYTHM; HORMONE SUBSTITUTION; HUMAN; PINEAL BODY; PRIORITY JOURNAL; REVIEW; SLEEP DISORDER;

EID: 0034987074     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(01)00120-6     Document Type: Article

References (96)

1. Plasma concentrations of melatonin in man following oral absorption of different preparations
2. Neurohormone melatonin prevents cell damage effect on gene expression for antioxidant enzymes
3. Immunoassay of 6-hydroxymelatonin sulphate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol
4. Efficacy of melatonin treatment in jet lag, shift work, and blindness
5. Low dose melatonin improves sleep in healthy middle-aged subjects
6. Evidence for modulation of melatonin secretion in men with benign and malignant tumors of the prostate: relationship with the pituitary hormones
7. Beta-adrenoceptor agonists do not stimulate daytime melatonin secretion in healthy subjects. A double blind placebo controlled study
8. Biochemical and ultrastructural approaches to the onset of the pineal melatonin rhythm in the rat
9. Factors influencing urinary 6-sulfatoxymelatonin, a major melatonin metabolite, in normal human subjects
10. Effect of melatonin in selected populations of sleep-disturbed patients
11. Hypothermic effect of melatonin and nocturnal core body temperature decline are reduced in aged women
12. Interactions of melatonin with membrane models: portioning of melatonin in AOT and lecithin reversed unicells
13. A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression
14. Atenolol reduces plasma melatonin concentration in man
15. Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration
16. Insomnia in older individuals: is early morning awakening the main problem?
17. Melatonin and sleep in humans
18. The hypothermic effect of melatonin on core body temperature: is more better?
19. Melatonin effect on daytime sleep in men: suppression of EEG low frequency activity and enhancement of spindle frequency activity
20. Neuroendocrine correlates of the aging brain in humans
21. Melatonin presents changes in microsomal membrane fluidity during induced lipid peroxidation
22. Daytime melatonin and temazepam in young adult humans: equivalent effects on sleep latency and body temperatures
23. β-adrenergic receptors in aged rat brain: reduced number and capacity of pineal to develop supersensitivity
24. Toxicology of melatonin
25. Impaired 6-sulfatoxymelatonin rhythms in the elderly: coincidence with sleep disorders
26. Melatonin replacement therapy of elderly insomniacs
27. Nocturnal plasma melatonin levels after flunitrazepam administration in healthy subjects
28. On the primary functions of melatonin in evolution: mediation of photoperiodic signals in a unicell photo-oxidation and scavenging of free radicals
29. Free radical theory of aging: the free radical diseases
30. Role of antioxidant nutrients in aging: overview
31. Sleep-promoting and hypothermic effects of daytime melatonin administration in humans
32. Age-dependent reduction in serum melatonin concentrations in healthy human subjects
33. Development of melatonin production in infants and the impact of prematurity
34. Urinary 6-sulfatoxymelatonin excretion and aging: new results and a critical review of the literature
35. Photoneural regulation of the mammalian pineal gland
36. Melatonin increases gene expression for antioxidant enzymes in rat brain cortex
37. Human melatonin secretion (I): a marker for adrenergic function
38. Light suppresses melatonin secretion in humans
39. Melatonin shifts human circadian rhythms according to a phase-response curve
40. Phase shifting the human circadian clock using melatonin
41. The human phase response curve (PRC) to melatonin is about 12h out of phase with the PRC light
42. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-ε4/4 genotype
43. Sleep complaints in community-dwelling older persons: prevalence, associated factors, and reported causes
44. Changes in endocrine circadian rhythms as markers of physiological and pathological brain aging
45. Effect of four-day nocturnal melatonin treatment on the 24h plasma melatonin, cortisol and prolactin profiles in humans
46. The correlation between plasma melatonin levels and urinary 6-hydroxymelatonin excretion
47. Melatonin regulation of melatonin receptor density in the rat pars tuberalis and suprachiasmatic nuclei
48. Age-related changes of neuro-endocrine-immune interactions in healthy humans
49. Maternal pinealectomy abolishes the diurnal rhythm in plasma melatonin concentrations in the fetal sheep and pregnant ewe during late gestation
50. Plasma melatonin - an index of brain aging in humans?
51. Melatonin improves evening napping
52. Hypnotic and hypothermic effects of melatonin on daytime sleep in humans: lack of antagonism by flumazenil
53. Use of melatonin to treat sleep disorders in tuberous sclerosis
54. Differential pattern of the circadian rhythm of serum melatonin in young and elderly healthy subjects
55. Pineal control of aging: effect of melatonin and pineal grafting on aging mice
56. Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum
57. Day-time melatonin administration: effects on core temperature and sleep onset latency
58. Synchronisation et dyschronisme des rythmes circadiens humains
59. Pineal melatonin rhythm: reduction in aging Syrian hamsters
60. Actions of melatonin in the reduction of oxidative stress
61. Melatonin madness
62. Human melatonin production decreases with age
63. Melatonin as a chronobiotic drug
64. Entrainment of free-running circadian rhythms by melatonin in blind people
65. Age-related differences in serum melatonin and pineal NAT activity and in the response of rat pineal to a 50-Hz magnetic field
66. Circadian rhythms of melatonin and cortisol in aging
67. 6-sulphatoxymelatonin production in breast cancer patients
68. Comparative study to determine the optimal melatonin dosage form for the alleviation of jet lag
69. Potent protective effects of melatonin on chromium(VI)-induced DNA strand breaks, cytotoxicity and lipid peroxidation in primary cultures of rat hepatocytes
70. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia
71. Melatonin: a potent endogenous hydroxyl radical scavenger
72. The histological appearance of the human pineal gland from puberty to old age
73. Melatonin secretion and age
74. Alterations with aging of the endocrine and neuroendocrine circadian system in humans
75. Age- and mental health-related circadian rhythms of plasma levels of melatonin, prolactin, luteinizing hormone and follicle stimulating hormone in man
76. Patterns of plasma melatonin with ageing and mental condition: stability of nyctohemeral rhythms and differences in seasonal variations
77. Age- and sex-associated modification of plasma melatonin concentration in man. Relationship to pathology, malignant or not, and autopsy findings
78. Age-related changes in both circadian and seasonal rhythms of rectal temperature with special reference to senile dementia of Alzheimer type
79. Melatonin possesses time-dependent hypnotic effects
80. The importance of timing in melatonin administration in a blind man
81. Daily rhythm of serum melatonin in patients with dementia of the degenerate type
82. Insomnia in the aged
83. Neuroendocrine rhythms and sleep in aging men
84. Nocturnal elevation of plasma melatonin and urinary 5-hydroxyindoleacetic acid in young men: attempts at modification by brief changes in environmental lighting and sleep by autonomic drugs
85. Bioavailability of oral melatonin in humans
86. Alterations in nocturnal serum melatonin levels in humans with growth and aging
87. 1-adrenergic receptors in selected hypothalamic regions
88. Age-related incidence of pineal gland calcification in children: a roentgenelogical study of 1044 skull films and a review of the literature
89. Age and enzyme activity in the human pineal
90. Effect of maternal pinealectomy and reverse photoperiod on the circadian melatonin rhythm in the sheep and fetus during the last trimester of pregnancy
91. Melatonin is able to influence its secretion in humans: description of a phase-response curve
92. Do plasma melatonin concentrations decline with age?
93. Effects of low oral doses of melatonin, given 2-4h before habitual bedtime, on sleep normal young humans